Nimbus Therapeutics is a clinical-stage, structure-based drug discovery company developing novel small molecule medicines designed to act against well-validated but difficult-to-drug targets implicated in multiple human diseases. The company advances promising research based on a unique strategy that combines leading-edge computational technologies with a tailored array of machine learning-based predictive modeling approaches. Nimbus' pipeline includes a clinical-stage HPK1 inhibitor for the treatment of cancer (NCT05128487), as well as a diverse portfolio of preclinical programs focused on cancer, including a WRN program for MSI-H cancers, autoimmune conditions, and metabolic diseases.
Company Details
- Employees
- 106
- Founded
- -
- Address
- 22 Boston Wharf Rd,
- Phone
- (857) 999-2009
- in****@****stx.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- nimbustx.com
- Keywords
- computational chemistry, biochemistry, small molecule therapeutics, oncology, immunology, metabolism, drug development.
- HQ
- Boston, Massachusetts
Nimbus Therapeutics Questions
Nimbus Therapeutics's helpline number is (857) 999-2009
Nimbus Therapeutics's website is nimbustx.com
Nimbus Therapeutics's LinkedIn profile is https://www.linkedin.com/company/nimbus-therapeutics
Nimbus Therapeutics has
106 employees.
View email and phone details for 106
employees at Nimbus Therapeutics.
Nimbus Therapeutics's industry is
Biotechnology Research
Nimbus Therapeutics's top competitors are
Apogee Therapeutics,
Rome Therapeutics,
Kymera Therapeutics,
Parabilis Medicines,
Cellarity,
Strand Therapeutics,
Beam Therapeutics,
Apollo Therapeutics,
Tessera Therapeutics,
Obsidian Therapeutics.
Nimbus Therapeutics's support email address is info@nimbustx.com
Nimbus Therapeutics's categories are Biotechnology Research
Nimbus Therapeutics's founding year is 2009
